TL;DR
A self-reporting nanovaccine engineered by coating TEVs under microfluidics with pH-sensitive manganese dioxide integrates immune activation with in vivo tracking, offering a precision strategy for cancer immunotherapy.
AI-generated by Semantic Scholar
Authors
Xiaoting Jiang, Jiacheng Song, Yunfei Mu, Guangyue Zu, Ruiheng Wang, Xisheng Liu, Xianguang Ding, Ting Chen
